These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1550968)

  • 1. Preclinical data and mode of action of amorolfine.
    Polak A
    Dermatology; 1992; 184 Suppl 1():3-7. PubMed ID: 1550968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections.
    Haria M; Bryson HM
    Drugs; 1995 Jan; 49(1):103-20. PubMed ID: 7705210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
    Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
    Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of amorolfine with various antifungal drugs in dermatophytosis.
    Polak A
    Mycoses; 1993; 36(1-2):43-9. PubMed ID: 8316261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo studies with flutrimazole, a new imidazole derivative with antifungal activity.
    García Rafanell J; Dronda MA; Merlos M; Forn J; Torres JM; Zapatero MI; Basi N
    Arzneimittelforschung; 1992 Jun; 42(6):836-40. PubMed ID: 1418042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal infections of the skin: infection process and antimycotic therapy.
    Borgers M; Degreef H; Cauwenbergh G
    Curr Drug Targets; 2005 Dec; 6(8):849-62. PubMed ID: 16375669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses.
    Clayton YM
    Br J Dermatol; 1994 Apr; 130 Suppl 43():7-8. PubMed ID: 8186143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the in vitro antifungal activity of amorolfine.
    De Vroey C; Desmet P; Li ZQ; Mukamurangwa P; Raes-Wuytack C
    Mycoses; 1996; 39(1-2):41-4. PubMed ID: 8786756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses.
    Nolting S; Semig G; Friedrich HK; Dietz M; Reckers-Czaschka R; Bergstraesser M; Zaug M
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():56-60. PubMed ID: 1458667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
    Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
    Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.
    Luna-Tapia A; Peters BM; Eberle KE; Kerns ME; Foster TP; Marrero L; Noverr MC; Fidel PL; Palmer GE
    Eukaryot Cell; 2015 Oct; 14(10):1006-16. PubMed ID: 26231054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorolfine spray in the treatment of foot mycoses (a dose-finding study).
    Nolting S; Reinel D; Semig G; Reckers-Czaschka R; Bergstraesser M; Zaug M
    Br J Dermatol; 1993 Aug; 129(2):170-4. PubMed ID: 7654578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antifungal activities of amorolfine against fresh isolates from patients with cutaneous mycosis].
    Uchida K; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 Sep; 44(9):1007-12. PubMed ID: 1960850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.
    Monk JP; Brogden RN
    Drugs; 1991 Oct; 42(4):659-72. PubMed ID: 1723367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
    Schaude M; Petranyi G; Ackerbauer H; Meingassner JG; Mieth H
    J Med Vet Mycol; 1990; 28(6):445-54. PubMed ID: 2093117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo.
    Polak A
    Arzneimittelforschung; 1982; 32(1):17-24. PubMed ID: 7037014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effect of amorolfine on experimental dermatophytosis].
    Uchida K; Matsuzaka A; Yamaguchi H
    Jpn J Antibiot; 1991 Sep; 44(9):1020-31. PubMed ID: 1960852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antifungal activity of amorolfine, a new morpholine antimycotic agent].
    Hiratani T; Asagi Y; Matsusaka A; Uchida K; Yamaguchi H
    Jpn J Antibiot; 1991 Sep; 44(9):993-1006. PubMed ID: 1960861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terconazole - a new broad-spectrum antifungal.
    Van Cutsem J; Van Gerven F; Zaman R; Janssen PA
    Chemotherapy; 1983; 29(5):322-31. PubMed ID: 6617296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.